These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8854244

  • 1. Effect of parathyroid hormone on renal calbindin-D28k.
    Hemmingsen C, Staun M, Lewin E, Nielsen PK, Olgaard K.
    J Bone Miner Res; 1996 Aug; 11(8):1086-93. PubMed ID: 8854244
    [Abstract] [Full Text] [Related]

  • 2. Regulation of renal calbindin-D28K.
    Hemmingsen C.
    Pharmacol Toxicol; 2000 Aug; 87 Suppl 3():5-30. PubMed ID: 11097107
    [Abstract] [Full Text] [Related]

  • 3. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM.
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [Abstract] [Full Text] [Related]

  • 4. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF.
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Calcium metabolic changes and calbindin-D in experimental hypertension.
    Hemmingsen C, Staun M, Lewin E, Egfjord M, Olgaard K.
    J Hypertens; 1994 Aug; 12(8):901-7. PubMed ID: 7814849
    [Abstract] [Full Text] [Related]

  • 7. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
    Cohen-Solal ME, Bouizar Z, Denne MA, Graulet AM, Gueris J, Bracq S, Jullienne A, de Vernejoul MC.
    Horm Metab Res; 1995 Sep; 27(9):403-7. PubMed ID: 8557238
    [Abstract] [Full Text] [Related]

  • 8. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
    Kinyamu HK, Gallagher JC, Petranick KM, Ryschon KL.
    J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA, Zysset E, Jenzer A, Thiébaud D, Ammann P, Rizzoli R, Jaquet-Müller F, Bonjour JP, Gertz B, Burckhardt P.
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [Abstract] [Full Text] [Related]

  • 10. Effects of magnesium on renal and intestinal calbindin-D.
    Hemmingsen C, Staun M, Olgaard K.
    Miner Electrolyte Metab; 1994 Apr; 20(5):265-73. PubMed ID: 7700214
    [Abstract] [Full Text] [Related]

  • 11. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [Abstract] [Full Text] [Related]

  • 12. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relaxant effects of parathyroid hormone(1-34) and parathyroid hormone-related protein(1-34) on ovine reticulo-ruminal smooth muscle in vivo.
    Care AD, Abbas SK, Harmeyer J, Boivin R.
    Exp Physiol; 1999 Jul; 84(4):665-75. PubMed ID: 10481224
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone related peptide (1-34) and 1,25-dihydroxyvitamin D, have no additive effects on bone tartrate resistant acid phosphatase activity in fetal rat calvaria cultures.
    de la Piedra C, Traba ML, Municio MJ, Torres R.
    Horm Metab Res; 1993 Aug; 25(8):417-20. PubMed ID: 8225185
    [Abstract] [Full Text] [Related]

  • 18. Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized rats.
    Horiuchi N.
    J Bone Miner Res; 1988 Jun; 3(3):353-8. PubMed ID: 3213628
    [Abstract] [Full Text] [Related]

  • 19. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
    Lewin E, Almaden Y, Rodriguez M, Olgaard K.
    Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.